Matthew Hershenhorn

Stock Analyst at Oppenheimer

(0.38)
# 4,140
Out of 4,947 analysts
1
Total ratings
n/a
Success rate
-4.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $108.89
Upside: +69.90%